Obesity Markers Linked to Cancer Risk in Barrettâ€™s Esophagus

For patients with Barrett’s esophagus, levels of leptin, high-molecular-weight adiponectin, and insulin resistance correlate with esophageal adenocarcinoma risk, according to a study published in the August issue of Clinical Gastroenterology and Hepatology.
http://www.doctorslounge.com/index.php/news/pb/39947

AUDIENCES

Caregivers
Friends and Family
General Public
Medical Profession
Patients
Survivors

SUBJECTS

Post Surgical

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino